MindBio debuts app.booze-ai.com to investors in Silicon Valley

Vancouver, British Columbia – TheNewswire - June 3, 2025 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6), (“MindBio”), (the “Company”), a clinical-stage biopharma/biotechnology company has today launched Booze AI, in Silicon Valley, debuting the world’s first AI-driven, voice-activated blood alcohol concentration (BAC) estimator for use on smartphones, tablets and computers to 150 institutional investors. This cutting-edge technology empowers users to monitor an estimate of their alcohol levels on the go, simply by talking to their smartphone and completing behavioural tasks, the novel software application delivering real-time insights to promote responsible drinking and prevent impaired driving.

app.booze-ai.com

Click Image To View Full Size

The novel intellectual property originates from MindBio’s drug trials and a range of studies the Company has conducted analysing the effects of drugs and alcohol intoxication on speech patterns. The Company has discovered the voice is a powerful external signal of health and can be used conveniently to predict and understand changes within the body without invasive tests.  

Click Image To View Full Size

Booze AI uses a proprietary prediction model to estimate BAC, using sophisticated machine learning techniques. Processing over 41 million data points collected from human trials and passing through user’s biophysical information the app detects changes in vocal frequency, power, amplitude and cognitive performance, comparing intoxication data to sober data.  In over 20,000 tests Booze AI has been successful estimating BAC 85% of the time within a range ±0.001 of commercial breathalyser results. Users submit baseline data and follow simple voice prompts to receive BAC estimates and warnings about alcohol’s impact on driving, and driving performance impairment.  The Company’s governing mantra is that there is zero amount of alcohol that is safe to drink then drive, even within the statutory and legal limits and Booze AI demonstrates the dangers of drink driving by predicting driving performance impairment, even after consuming small amounts of alcohol.

Booze AI’s proprietary BAC-Regress 0.1 model, has resolved complexities like mouth alcohol residue which is problematic for commercial alcohol breath testing and the AI models, learn about users over time.  Available for download today with a 75% discount, at app.booze-ai.com Booze AI is a user-friendly tool with significant potential for intoxication detection, drink driving deterrence and harm reduction.  The Booze AI app can be easily saved to the home screen on any smartphone or tablet, for convenient use.

“Booze AI is a transformative step in alcohol safety,” said Justin Hanka, CEO of MindBio. “By merging AI innovation with a strong anti-drink-driving educational mission, we aim to save lives through informed decision-making.  Launching the Booze AI app in Silicon Valley is an exceptional milestone for the Company”

For further information, please contact:

 

Justin Hanka, Chief Executive Officer

61 433140886

justin@mindbiotherapeutics.com

 

Media Inquiries

Kristina Spionjak

pr@hlthcommunications.com

  

Cautionary Note Concerning Forward-Looking Statements:

The press release contains "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "budget," "believe," "project," "estimate," "expect," "scheduled," "forecast," "strategy," "future," "likely," "may," "to be," "could," "would," "should," "will" and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and conditional. Forward-looking statements are based on assumptions as of the date they are provided. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Additionally, there are known and unknown risk factors that could cause the Company's actual results and financial conditions to differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important risk factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements, include among others: general economic, market and business conditions in Canada and Australia; market volatility; unforeseen delays in timelines for any of the transactions or events described in this press release.  All forward-looking information is qualified in its entirety by this cautionary statement.

The Company disclaims any obligation to revise or update any such forward-looking statement or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.